Drug intelligence / Profile preview

viscosine

Development stage
Preclinical
Modality
Small Molecules
Administration
Injection
01

Overview

Viscosine is a naturally occurring C-alkylated flavonoid (4',5,7-trihydroxy-3,6-dimethoxyflavone) isolated from the medicinal plant *Dodonaea viscosa*. It is a small molecule research compound currently being investigated as a potential lead for the development of antipyretic, anti-inflammatory, and analgesic therapeutics. Its primary biological activity involves the inhibition of microsomal prostaglandin E synthase-1 (mPGES-1), which subsequently reduces the production of prostaglandin E2 (PGE2), a key mediator of fever and inflammation. Preclinical studies in animal models have also demonstrated that viscosine possesses hepatoprotective properties and acts as a lipoxygenase inhibitor. Furthermore, in silico studies have suggested potential cytotoxic activity against cancer cells, although it remains in the early research and preclinical stages.

Other names
4',5,7-trihydroxy-3,6-dimethoxyflavone3,6-dimethoxy-4',5,7-trihydroxyflavone5,7-dihydroxy-2-(4-hydroxyphenyl)-3,6-dimethoxy-4H-chromen-4-one
02

Targets

15-LOX (Lysyl Oxidase)PTGES (Microsomal prostaglandin E synthase-1)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on viscosine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on viscosine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call